Guardant Health
416 hedge funds and large institutions have $11B invested in Guardant Health in 2021 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 188 increasing their positions, 106 reducing their positions, and 62 closing their positions.
77% more repeat investments, than reductions
Existing positions increased: 188 | Existing positions reduced: 106
7% more call options, than puts
Call options by funds: $94.9M | Put options by funds: $88.5M
0% less funds holding
Funds holding: 418 → 416 (-2)
3% less first-time investments, than exits
New positions opened: 60 | Existing positions closed: 62
2.39% less ownership
Funds ownership: 90.99% → 88.6% (-2.4%)
21% less capital invested
Capital invested by funds: $13.9B → $11B (-$2.91B)
60% less funds holding in top 10
Funds holding in top 10: 10 → 4 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$180M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$110M |
| 3 |
Coatue Management
New York
|
+$86.5M |
| 4 |
LSCM
Light Street Capital Management
Palo Alto,
California
|
+$68.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$65.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
-$750M |
| 2 |
Jennison Associates
New York
|
-$275M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$143M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$94.6M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$85.7M |
GH Hedge Fund Activity: Q2 2021 in Review
416 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q2 2021, worth a combined $11B — down 21% from $13.9B a quarter earlier.
Sellers outnumbered buyers: 62 funds closed out of GH and 60 opened new positions — a net loss of 2 holders — while 106 trimmed existing stakes and 188 added.
The largest buyer was Viking Global Investors, adding an estimated $180M. The largest seller was SB Investment Advisers (UK), cutting an estimated $750M.
- 416 institutional investors held Guardant Health (GH) as of Q2 2021, down from 418 in Q1 2021.
- Funds reported $11B of Guardant Health stock for Q2 2021, down 21% quarter-over-quarter.
- 60 funds opened new Guardant Health positions in Q2 2021 and 62 closed out, a net change of -2 holders.
- The largest Guardant Health buyer in Q2 2021 was Viking Global Investors, an estimated $180M added.
- The largest Guardant Health seller in Q2 2021 was SB Investment Advisers (UK), an estimated $750M sold.
Based on aggregated 13F filings for Q2 2021.